Yong Huo
Tracked across 1 events · 8 articles · First seen Jun 26, 2026 · Last active Jun 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Professor Yong Huo, a leading principal investigator, provided expert commentary on the urgent need for innovative treatment options for hypercholesterolemia and the positive results of Lerociclib's clinical trials.
Jun 26, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Yong Huo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard